Incidence and Risk Factors for Rejection After Conversion to Sirolimus-Based Immunosuppression in Orthotopic Heart Transplant Recipients

被引：0
|
作者：
Inglis, S. [1 ]
Abbas, M. [1 ]
Asleh, R. [1 ]
Kushwaha, S. [1 ]
Clavell, A. [1 ]
Villavicencio, M. [1 ]
Spencer, P. [1 ]
Daly, R. [1 ]
Behfar, A. [1 ]
Rosenbaum, A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
197
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Posttransplantation conversion to sirolimus-based immunosuppression: A single center experience
    Saber, L. T. Santamaria
    Ikeda, M. Y.
    Almeida, J. M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3098 - 3100
  • [22] Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
    Asleh, Rabea
    Vucicevic, Darko
    Petterson, Tanya M.
    Kremers, Walter K.
    Pereira, Naveen L.
    Daly, Richard C.
    Edwards, Brooks S.
    Steidley, D. Eric
    Scott, Robert L.
    Kushwaha, Sudhir S.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [23] Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients
    Morard, Isabelle
    Dumortier, Jerome
    Spahr, Laurent
    Hadengue, Antoine
    Majno, Pietro
    Morel, Philippe
    Mentha, Gilles
    Giostra, Emiliano
    LIVER TRANSPLANTATION, 2007, 13 (05) : 658 - 664
  • [24] Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients
    Loar, Robert W.
    Driscoll, David J.
    Kushwaha, Sudhir S.
    Cramer, Carl H.
    O'Leary, Patrick W.
    Daly, Richard C.
    Mauriello, Daniel A.
    Johnson, Jonathan N.
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 794 - 799
  • [25] Sirolimus-based immunosuppression for transplant-associated thrombotic microangiopathy
    Edwards, C
    House, A
    Shahinian, V
    Knoll, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (08) : 1524 - 1526
  • [26] Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients
    Nseir, G.
    Venetz, J. -P
    Hadaya, K.
    Buhler, L.
    Martin, P-Y
    Pascual, M.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 18S - 18S
  • [27] Sirolimus Based Immunosuppression Results in Lower Incidence of Post-Transplantation Lymphoproliferative Disorders in Heart Transplant Recipients
    Vucicevic, D.
    Daly, R. C.
    Steidley, D. E.
    Scott, R. L.
    Kremers, W. K.
    Edwards, B. S.
    Sudhir, K. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S86 - S86
  • [28] A Randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
    Watson, Christopher J. E.
    Gimson, Alexander E. S.
    Alexander, Graerne J.
    Allison, Michael E. D.
    Gibbs, Paul
    Smith, Jane C.
    Palmer, Christopher R.
    Bradley, J. Andrew
    LIVER TRANSPLANTATION, 2007, 13 (12) : 1694 - 1702
  • [29] Improvement in Renal Function After Late Conversion to Sirolimus-Based Immunosuppression in Composite Tissue Allotransplantation
    Landin, Luis
    Cavadas, Pedro C.
    Rodriguez-Perez, Jose C.
    Garcia-Bello, Miguel A.
    Garcia-Cosmes, Pedro
    Thione, Alessandro
    Vera-Sempere, Francisco
    Alfaro, Luis
    TRANSPLANTATION, 2010, 90 (06) : 691 - 692
  • [30] Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients
    Rajab, A.
    Pelletier, R.
    Elkhammas, E.
    Bumgardner, G.
    El-Hinnawi, A.
    Henry, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345